356 related articles for article (PubMed ID: 35380239)
1. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Rosenberg CA; Bill M; Kerndrup GB; Ebbesen LH; Hansen MH; Roug AS; Ludvigsen M
Bone Marrow Transplant; 2022 Mar; 57(3):460-465. PubMed ID: 35027675
[TBL] [Abstract][Full Text] [Related]
3. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
Lackraj T; Ben Barouch S; Medeiros JJF; Pedersen S; Danesh A; Bakhtiari M; Hong M; Tong K; Joynt J; Arruda A; Minden MD; Kuruvilla J; Bhella S; Kukreti V; Crump M; Prica A; Chen C; Deng Y; Xu W; Pugh TJ; Keating A; Dick JE; Abelson S; Kridel R
Am J Hematol; 2022 Dec; 97(12):1538-1547. PubMed ID: 36087071
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.
Akhtari M; Bhatt VR; Tandra PK; Krishnamurthy J; Horstman H; Dreessen A; Chen PX; Armitage JO
Cancer Biol Ther; 2013 Dec; 14(12):1077-88. PubMed ID: 24025414
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis with
Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Kerndrup GB; Hansen MC; Ewald IKL; Bill M; Ebbesen LH; Rosenberg CA; Hokland P; Ludvigsen M; Stidsholt Roug A
Blood Adv; 2020 Mar; 4(5):885-892. PubMed ID: 32150606
[TBL] [Abstract][Full Text] [Related]
9. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.
Yan C; Richard MA; Gibson CJ; He J; Bosworth A; Crossman DK; Singh P; Hageman L; Kalra R; Armenian SH; Vose J; Weisdorf DJ; Ebert BL; Yasui Y; Forman SJ; Bhatia R; Bhatia S
J Clin Oncol; 2024 Apr; ():JCO2302547. PubMed ID: 38635938
[TBL] [Abstract][Full Text] [Related]
10. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.
Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J
Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study.
Hazenberg CLE; de Graaf AO; Mulder R; Bungener LB; van Bergen MGJM; Mulder AB; Choi G; Schuringa JJ; de Groot MR; Vellenga E; Jansen JH; Huls G; van Zeventer IA
Blood Adv; 2023 Apr; 7(7):1269-1278. PubMed ID: 36219593
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis in hematopoietic stem cell transplantation.
Wilk CM; Manz MG; Boettcher S
Curr Opin Hematol; 2021 Mar; 28(2):94-100. PubMed ID: 33394723
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis in the setting of hematopoietic cell transplantation.
Gibson CJ; Lindsley RC; Gondek LP
Semin Hematol; 2024 Feb; 61(1):9-15. PubMed ID: 38429201
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.
Heini AD; Porret N; Zenhaeusern R; Winkler A; Bacher U; Pabst T
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202404
[TBL] [Abstract][Full Text] [Related]
15. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
[TBL] [Abstract][Full Text] [Related]
16. Compartment-specific mutational landscape of clonal hematopoiesis.
Hartmann L; Hecker JS; Rothenberg-Thurley M; Rivière J; Jentzsch M; Ksienzyk B; Buck MC; van der Garde M; Fischer L; Winter S; Rauner M; Tsourdi E; Weidner H; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Lützner J; Goralski S; Bassermann F; Spiekermann K; Hofbauer LC; Schwind S; Platzbecker U; Götze KS; Metzeler KH
Leukemia; 2022 Nov; 36(11):2647-2655. PubMed ID: 36131041
[TBL] [Abstract][Full Text] [Related]
17. Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective.
Hayashi Y; Harada Y; Harada H
Leukemia; 2022 May; 36(5):1203-1214. PubMed ID: 35354921
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy.
Xie Z; Lasho T; Khurana A; Ferrer A; Finke C; Mangaonkar AA; Ansell S; Fernandez J; Shah MV; Al-Kali A; Gangat N; Abeykoon J; Witzig TE; Patnaik MM
Haematologica; 2024 Feb; 109(2):509-520. PubMed ID: 37646653
[TBL] [Abstract][Full Text] [Related]
19. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]